IL32 and systemic sclerosis: We observed that IL-32 sera levels were higher in patients with PAH; on the contrary, those levels were quite undetectable in SSc patients without PAH and HCs, confirming the relevance of this cytokine in highlighting the presence of WHO group 1 PAH.